I thought at best we’d see no increased disability,” says Kerr. “Instead, we demonstrated a 41 percent average reduction in disability”—a reduction that persisted. Pretty heady stuff considering that the most potent therapy for MS on the market “shows a 17 percent increase in disability over two years,” says Kerr.
A long but lovely article about something I’d heard nothing about until today. Whenever somebody’s fans mentions cure and Nobel in the same article, I perk up my ears.